Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population

Infection, Genetics and Evolution

Volumn 27, Issue , 2014, Pages 69-76

  Liu, Yanqiong ^a   Liu, Yan ^a   Huang, Xiamei ^a   Sui, Jingzhe ^a   Mo, Cuiju ^a   Wang, Jian ^a   Peng, Qiliu ^a   Deng, Yan ^a   Huang, Li ^a   Li, Shan ^a   Qin, Xue ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Chronic hepatitis B; Estrogen receptor alpha; Hepatocellular carcinoma; Liver cirrhosis; Polymorphism

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADULT; ALLELE; ARTICLE; CANCER RISK; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; ESR1 GENE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS B; HUMAN; INFECTION RISK; INTRON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ESTROGEN RECEPTOR ALPHA GENE; GENETIC POLYMORPHISM; HAPLOTYPE; HOMOZYGOSITY; INFECTION SENSITIVITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; COMPLICATION; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; HEPATITIS B VIRUS; MIDDLE AGED; ODDS RATIO; POPULATION GENETICS; RISK FACTOR;

ADULT; ALLELES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84904655946     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.07.002     Document Type: Article

References (31)

1. Ahlbory-Dieker D.L., Stride B.D., Leder G., Schkoldow J., Trolenberg S., Seidel H., Otto C., Sommer A., Parker M.G., Schutz G., Wintermantel T.M. DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus. Mol. Endocrinol. 2009, 23:1544-1555.
2. Bakr I., Rekacewicz C., El Hosseiny M., Ismail S., El Daly M., El-Kafrawy S., Esmat G., Hamid M.A., Mohamed M.K., Fontanet A. Higher clearance of hepatitis C virus infection in females compared with males. Gut 2006, 55:1183-1187.
3. Chattopadhyay S., Siddiqui S., Akhtar M.S., Najm M.Z., Deo S.V., Shukla N.K., Husain S.A. Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India. Tumour Biol. 2014, 35:4517-4527.
4. Chen C.J., Yu M.W., Liaw Y.F. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1997, 12:S294-S308.
5. Chuang S.C., La Vecchia C., Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009, 286:9-14.
6. Deng G., Zhou G., Zhai Y., Li S., Li X., Li Y., Zhang R., Yao Z., Shen Y., Qiang B., Wang Y., He F. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 2004, 40:318-326.
7. Di Martino V., Lebray P., Myers R.P., Pannier E., Paradis V., Charlotte F., Moussalli J., Thabut D., Buffet C., Poynard T. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 2004, 40:1426-1433.
8. Doherty J.A., Rossing M.A., Cushing-Haugen K.L., Chen C., Van Den Berg D.J., Wu A.H., Pike M.C., Ness R.B., Moysich K., Chenevix-Trench G., Beesley J., Webb P.M., Chang-Claude J., Wang-Gohrke S., Goodman M.T., Lurie G., Thompson P.J., Carney M.E., Hogdall E., Kjaer S.K., Hogdall C., Goode E.L., Cunningham J.M., Fridley B.L., Vierkant R.A., Berchuck A., Moorman P.G., Schildkraut J.M., Palmieri R.T., Cramer D.W., Terry K.L., Yang H.P., Garcia-Closas M., Chanock S., Lissowska J., Song H., Pharoah P.D., Shah M., Perkins B., McGuire V., Whittemore A.S., Di Cioccio R.A., Gentry-Maharaj A., Menon U., Gayther S.A., Ramus S.J., Ziogas A., Brewster W., Anton-Culver H., Australian Ovarian Cancer Study Management G., Australian Cancer S., Pearce C.L., Ovarian Cancer Association C. Polymorphism and invasive epithelial ovarian cancer risk an ovarian cancer association consortium study. Cancer Epidemiol. Biomarkers Prev. 2010, 19:245-250.
9. Feng Y., Lin X., Zhou S., Xu N., Yi T., Zhao X. The associations between the polymorphisms of the ER-alpha gene and the risk of uterine leiomyoma (ULM). Tumour Biol. 2013, 34:3077-3082.
10. Ferlay, J., Soerjomataram, I., Ervik, M., et al., 2013. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France, International Agency for Research on Cancer.(Accessed 15 May 2014). http://www.globocan.iarc.fr.
11. Figtree G.A., Noonan J.E., Bhindi R., Collins P. Estrogen receptor polymorphisms: significance to human physiology, disease and therapy. Recent Pat. DNA Gene. Seq. 2009, 3:164-171.
12. Giannitrapani L., Soresi M., La Spada E., Cervello M., D'Alessandro N., Montalto G. Sex hormones and risk of liver tumor. Ann. N.Y. Acad. Sci. 2006, 1089:228-236.
13. Ha N.B., Ha N.B., Ahmed A., Ayoub W., Daugherty T.J., Chang E.T., Lutchman G.A., Garcia G., Cooper A.D., Keeffe E.B., Nguyen M.H. Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. Cancer Causes Control 2012, 23:455-462.
14. Herrington D.M., Howard T.D., Brosnihan K.B., McDonnell D.P., Li X., Hawkins G.A., Reboussin D.M., Xu J., Zheng S.L., Meyers D.A., Bleecker E.R. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002, 105:1879-1882.
15. International HapMap C. The international HapMap project. Nature 2003, 426:789-796.
16. Li L., Zhang X., Xia Q., Ma H., Chen L., Hou W. Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk. Tumour Biol. 2014, 35:4629-4635.
17. Nagasue N., Ito A., Yukaya H., Ogawa Y. Estrogen receptors in hepatocellular carcinoma. Cancer 1986, 57:87-91.
18. Peng Q., Qin X., He Y., Chen Z., Deng Y., Li T., Xie L., Zhao J., Li S. Association of IL27 gene polymorphisms and HBV-related hepatocellular carcinoma risk in a Chinese population. Infect Genet. Evol. 2013, 16:1-4.
19. Porter L.E., Elm M.S., Van Thiel D.H., Eagon P.K. Hepatic estrogen receptor in human liver disease. Gastroenterology 1987, 92:735-745.
20. Poynard T., Ratziu V., Charlotte F., Goodman Z., McHutchison J., Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J. Hepatol. 2001, 34:730-739.
21. Rossini G.P., Baldini G.M., Villa E., Manenti F. Characterization of estrogen receptor from human liver. Gastroenterology 1989, 96:1102-1109.
22. Shimizu I. Impact of oestrogens on the progression of liver disease. Liver Int. 2003, 23:63-69.
23. Shimizu I., Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol. Res. 2007, 37:239-247.
24. Shimizu I., Kohno N., Tamaki K., Shono M., Huang H.W., He J.H., Yao D.F. Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J. Gastroenterol. 2007, 13:4295-4305.
25. Slattery M.L., Sweeney C., Murtaugh M., Ma K.N., Wolff R.K., Potter J.D., Caan B.J., Samowitz W. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2936-2942.
26. Villa E., Baldini G.M., Rossini G.P., Pasquinelli C., Melegari M., Cariani E., Tata C., Bellentani S., Ferrari A., Manenti F. Ethanol-induced increase in cytosolic estrogen receptors in human male liver: a possible explanation for biochemical feminization in chronic liver disease due to alcohol. Hepatology 1988, 8:1610-1614.
27. Wands J. Hepatocellular carcinoma and sex. N. Engl. J. Med. 2007, 357:1974-1976.
28. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 2000, 67-73.
29. Yan Z., Tan W., Xu B., Dan Y., Zhao W., Deng C., Chen W., Tan S., Mao Q., Wang Y., Deng G. A cis-acting regulatory variation of the estrogen receptor alpha (ESR1) gene is associated with hepatitis B virus-related liver cirrhosis. Hum. Mutat. 2011, 32:1128-1136.
30. Zhai Y., Zhou G., Deng G., Xie W., Dong X., Zhang X., Yu L., Yang H., Yuan X., Zhang H., Zhi L., Yao Z., Shen Y., Qiang B., He F. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Gastroenterology 2006, 130:2001-2009.
31. Zhou X., Gu Y., Wang D.N., Ni S., Yan J. Eight functional polymorphisms in the estrogen receptor 1 gene and endometrial cancer risk: a meta-analysis. PLoS ONE 2013, 8:e60851.